Slomovitz BM - Search Results

1

Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.

Ramirez PT, Slomovitz BM, McQuinn L, Levenback C, Coleman RL. Ramirez PT, et al. Among authors: slomovitz bm. Gynecol Oncol. 2006 Dec;103(3):888-90. doi: 10.1016/j.ygyno.2006.05.021. Epub 2006 Jun 27. Gynecol Oncol. 2006. PMID: 16806436

2

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?

Mahdi H, Ray-Coquard I, Lorusso D, Mirza MR, Monk BJ, Slomovitz B. Mahdi H, et al. Int J Gynecol Cancer. 2023 Nov 6;33(11):1675-1681. doi: 10.1136/ijgc-2023-004454. Int J Gynecol Cancer. 2023. PMID: 37640446 Free PMC article. Review.

3

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.

Ray-Coquard I, Monk BJ, Lorusso D, Mahdi H, Upadhyay V, Graul R, Husain A, Mirza MR, Slomovitz B. Ray-Coquard I, et al. Int J Gynecol Cancer. 2023 Dec 4;33(12):1943-1949. doi: 10.1136/ijgc-2023-004739. Int J Gynecol Cancer. 2023. PMID: 37907262 Free PMC article. Review.

4

Immunotherapy in endometrial cancer.

Mahdi H, Chelariu-Raicu A, Slomovitz BM. Mahdi H, et al. Among authors: slomovitz bm. Int J Gynecol Cancer. 2023 Mar 6;33(3):351-357. doi: 10.1136/ijgc-2022-003675. Int J Gynecol Cancer. 2023. PMID: 36878570 Review.

5

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.

Colombo N, Lorusso D, Monk BJ, Slomovitz B, Hasegawa K, Nogueira-Rodrigues A, Zale M, Okpara CE, Barresi G, McKenzie J, Makker V. Colombo N, et al. Oncologist. 2024 Jan 5;29(1):25-35. doi: 10.1093/oncolo/oyad201. Oncologist. 2024. PMID: 37523661 Free PMC article.

6

Desmoplastic small round cell tumor with primary ovarian involvement: case report and review.

Slomovitz BM, Girotra M, Aledo A, Saqi A, Soslow RA, Spigland NA, Caputo TA. Slomovitz BM, et al. Gynecol Oncol. 2000 Oct;79(1):124-8. doi: 10.1006/gyno.2000.5829. Gynecol Oncol. 2000. PMID: 11006044 Review.

7

Ovarian mucinous cystadenocarcinoma with virilization.

Nezhat F, Slomovitz BM, Saiz AD, Cohen CJ. Nezhat F, et al. Among authors: slomovitz bm. Gynecol Oncol. 2002 Mar;84(3):468-72. doi: 10.1006/gyno.2001.6542. Gynecol Oncol. 2002. PMID: 11855891

8

Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy.

Slomovitz BM, Soslow RA, Chang RC, Golub R, Kuo DY. Slomovitz BM, et al. Gynecol Oncol. 2002 Oct;87(1):152-4. doi: 10.1006/gyno.2002.6790. Gynecol Oncol. 2002. PMID: 12468359

9

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

10

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Slomovitz BM, et al. Obstet Gynecol. 2004 Aug;104(2):255-60. doi: 10.1097/01.AOG.0000131620.67911.03. Obstet Gynecol. 2004. PMID: 15291996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page